Table 1.
Exposure | Protein (μg/ml) | Total leukocytes × 104 | Macrophages × 104 (%) | Eosinophils × 104 (%) | Lymphocytes × 104 (%) |
---|---|---|---|---|---|
Control (unexposed) | 130 ± 10 | 3.7 ± 0.6 | 3.7 ± 0.6 | 0 | 0 |
(>98) | (<1) | (<1) | |||
Acute | |||||
1 day | 155 ± 21 | 5.3 ± 0.4 | 5.1 ± 0.5 | 0 | 0 |
(96 ± 2) | (<1) | (<1) | |||
3 days | 136 ± 18 | 13 ± 2* | 6.5 ± 1.0* | 5 ± 2* | 1.3 ± 0.3 |
(54 ± 12*) | (34 ± 10*) | (10 ± 2*) | |||
5 days | 232 ± 25* | 48 ± 9* | 7.0 ± 5.0* | 30 ± 5* | 9.4 ± 2.0* |
(20 ± 5*) | (60 ± 7*) | (19 ± 2*) | |||
7 days | 305 ± 89* | 132 ± 7* | 13 ± 2* | 91 ± 9* | 28 ± 5* |
(10 ± 1*) | (68 ± 4*) | (21 ± 5*) | |||
10 days | 280 ± 17* | 147 ± 10* | 11 ± 5* | 106 ± 20* | 32 ± 10* |
(8 ± 2*) | (73 ± 2*) | (19 ± 3*) | |||
Chronic | |||||
3 weeks | 203 ± 29* | 124 ± 16* | 56 ± 11* | 28 ± 9* | 39 ± 13* |
(45 ± 10*) | (22 ± 6*) | (31 ± 5*) | |||
6 weeks | 178 ± 19 | 6.4 ± 1.7 | 4.5 ± 1.0 | 0 | 1.9 ± 1* |
(71 ± 2*) | (<1) | (29 ± 1*) |
For acute exposure, as described in Materials and Methods, mice were immunized with i.p. OVA/alum weekly for 3 weeks and were then exposed to aerosolized OVA for 1 to 10 days. Twenty-four hours after the last aerosol OVA challenge, mice were sacrificed. For chronic exposure, mice were immunized with 3 weekly i.p. OVA/alum injections as above and then were exposed to aerosolized OVA 5 days/week for 3 to 6 weeks. Twenty-four hours after the last aerosol OVA challenge, mice were sacrificed. BAL cells were counted, and cytospin preparations were stained to obtain the differential leukocyte count. Data represent mean ± SEM values; n = 4 to 8 mice/time point.
*P < 0.05 versus control mice.